What this record means
The record shows that “ALPHABET HEALTH” is a live, registered service mark owned by Alphabet Health Ltd., a corporation organized in New York. The mark is on the Principal Register and covers advertising, business consulting, brand development, market analysis, and related services specifically for pharmaceuticals, as listed in class 035. A similar name would raise the closest concern in the pharmaceutical advertising and consulting space, where the goods and services overlap directly. The record does not give the owner control over every use of the word “Health” or “Alphabet” outside that specific pharmaceutical context. The prosecution history shows a final refusal in November 2019, followed by a successful registration on June 23, 2020, with no enforcement actions recorded. The latest event is the 6‑year maintenance reminder sent on June 23, 2025. For anyone looking to use a similar name, the primary risk lies in the pharmaceutical advertising and consulting sector; use elsewhere may be less problematic but is not guaranteed safe.
Informational only - not legal advice.Goods & services
Cl. 035Advertising & Business
ACTIVE Advertising agencies specializing in pharmaceutical branding, product launch, and consulting; Advertising services in the field of pharmaceuticals; Advertising services, namely, promoting and marketing the goods and services of others in the field of pharmaceuticals via print and electronic media; Advertising, marketing and promotion services in the field of pharmaceuticals; Brand concept and brand development services for corporate clients in the field of pharmaceuticals; Business consultation in the field of pharmaceuticals; Concept and brand development in the field of pharmaceuticals; Market analysis and research services in the field of pharmaceuticals; Marketing consultation in the field of pharmaceuticals; Providing advertising, marketing and promotional services for the pharmaceutical and medical industry; Providing advertising, marketing and promotional services for the pharmaceutical and medical products of others
First use: Nov 26, 2018
Use in commerce: Nov 26, 2018
